Biovica Granted Japanese Patent for Immuno-Oncology

Biovica, specializing in blood-based cancer monitoring, today announced that the Japanese Patent Office has granted a new patent covering the use of TKa in relation to immune checkpoint inhibitor treatment in cancer patients.The granting expands …